Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.77 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.53 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.576ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.325ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.521ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.206ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
unclassifiableENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCEENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KW.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
KP.3.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used